United States · FDA National Drug Code directory
Rasagiline
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 0093-3060_dc5c47b7-316b-4342-878b-d0dcbe0387f0
- Product NDC
- 0093-3060
- Form
- TABLET
- Composition / generic term
- Rasagiline
- Labeler
- Teva Pharmaceuticals USA, Inc.
- Marketing category
- NDA AUTHORIZED GENERIC
- Marketing start / end (source format)
- 20170103
- Source listing expiry
- 20271231
Source-listed ingredients
- RASAGILINE MESYLATE — .5 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 30 TABLET in 1 BOTTLE (0093-3060-56) · 0093-3060-56
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →